Cerebrospinal Fluid Penetrance of Daratumumab in Leptomeningeal Multiple Myeloma

Lignende værker

• CD38-targeted therapy with daratumumab reduces autoantibody levels in multiple myeloma patients
  af: Kristine A. Frerichs, et al.
  Udgivet: (2019-12-01)
• Retrospective Longitudinal Monitoring of Multiple Myeloma Patients by Mass Spectrometry Using Archived Serum Protein Electrophoresis Gels and De Novo Sequence Analysis
  af: Somayya Noori, et al.
  Udgivet: (2022-08-01)
• Effect of daratumumab on normal plasma cells, polyclonal immunoglobulin levels, and vaccination responses in extensively pre-treated multiple myeloma patients
  af: Kristine A. Frerichs, et al.
  Udgivet: (2020-06-01)
• Daratumumab-mediated lysis of primary multiple myeloma cells is enhanced in combination with the human anti-KIR antibody IPH2102 and lenalidomide
  af: Inger S. Nijhof, et al.
  Udgivet: (2015-02-01)
• Leptomeningeal Metastasis: The Role of Cerebrospinal Fluid Diagnostics
  af: Lena Bönig, et al.
  Udgivet: (2019-08-01)